Trial Profile
Study of Apatinib in Patients With Local Advanced 131iodine 131I -Refractory/Resistant Differentiated Thyroid Cancer
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Rivoceranib (Primary)
- Indications Thyroid cancer
- Focus Therapeutic Use
- 11 Apr 2016 New trial record